SAN DIEGO & DENVER--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces DaVita Inc. (NYSE: DVA) may face damages caused by a pending securities lawsuit action lawsuit. DaVita Inc. provides kidney dialysis services.
View this press release on the firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/davita-inc-apr-19/
Shareholder Class Action Alleging DaVita Made Materially False and Misleading Statements Survives Motion to Dismiss
Investors filed a class action complaint against DaVita for alleged violations of the Securities Exchange Act of 1934. According to the complaint, DaVita may have been illegally obtaining revenues and profits by steering patients into unnecessary private insurance plans and using the American Kidney Fund as a vehicle to facilitate its scheme. On March 28, 2019, U.S. District Court Judge William J. Martinez denied DaVita's motion to dismiss plaintiffs' complaint, paving the way for litigation to proceed.
DaVita Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Leonid Kandinov at (800) 350-6003, LKandinov@robbinsarroyo.com, or via the shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Sign up for our FREE portfolio monitoring service, Stock Watch.
Attorney Advertising. Past results do not guarantee a similar outcome.